Omicron: a drug developer’s perspective
Author:
Affiliation:
1. Abimmune Biopharma, Inc., San Diego, CA, USA
2. Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX, USA
Publisher
Informa UK Limited
Subject
Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology
Link
https://www.tandfonline.com/doi/pdf/10.1080/22221751.2021.2023330
Reference20 articles.
1. The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages
2. Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape
3. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
4. Rapid characterization of spike variants via mammalian cell surface display
5. Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Would the Development of a Multitarget Inhibitor of 3CLpro and TMPRSS2 be Promising in the Fight Against SARS-CoV-2?;Medicinal Chemistry;2023-06
2. Multi‐omic and comparative analyses revealed monocyte‐derived alpha‐defensin‐1 correlated with COVID‐19 severity and inhibited SARS‐CoV‐2 infection;Journal of Medical Virology;2023-05-31
3. Prevalence of taste and smell dysfunction in mild and asymptomatic COVID-19 patients during Omicron prevalent period in Shanghai, China: a cross-sectional survey study;BMJ Open;2023-03
4. Inhalable neutralizing antibodies – promising approach to combating respiratory viral infections;Trends in Pharmacological Sciences;2023-02
5. Sotrovimab use in Japanese inpatients with COVID-19: post-infusion adverse events;BMC Infectious Diseases;2022-12-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3